Onasemnogene abeparvovec Completed Phase 1 Trials for Spinal Muscular Atrophy 1 Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02122952Gene Transfer Clinical Trial for Spinal Muscular Atrophy Type 1